Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous
studies; however, a large portion of the genetic risk for this disease remains unexplained. …

The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association
study of late-onset Alzheimer disease using a three-stage design consisting of a discovery …

We developed a generalized framework for multiplexed resequencing of targeted human
genome regions on the Illumina Genome Analyzer using degenerate indexed DNA bar codes …

Angiotensin converting enzyme 2 (ACE2), a newly discovered member of the renin–angiotensin
system (RAS), is a potential therapeutic target for the control of cardiovascular disease …

INTRODUCTION Brain disorders may exhibit shared symptoms and substantial epidemiological
comorbidity, inciting debate about their etiologic overlap. However, detailed study of …

Angiotensin-converting enzyme 2 (ACE2) is considered an important therapeutic target for
controlling cardiovascular diseases and severe acute respiratory syndrome (SARS) outbreaks…

<p id="p001">Contactin-associated protein-like 2 (CASPR2) is encoded by <italic>CNTNAP2</italic>
and clusters voltage-gated potassium channels (K_v1.1) at the nodes …

Background Approximately 90% of persons with amyotrophic lateral sclerosis (ALS) have
the sporadic form, which may be caused by the interaction of multiple environmental factors …

Background We have previously characterised functional brain abnormalities in young
adults at genetic risk for late-onset Alzheimer's disease. To gain further knowledge on the …

It is widely assumed that genetic differences in gene expression underpin much of the difference
among individuals and many of the quantitative traits of interest to geneticists. Despite …